Exploring Novel Approaches With PI3K Inhibitors in R/R Follicular and Marginal Zone Lymphoma
Nov 3, 2021
30:25
Episode Description
Experts discuss the role of PI3K inhibitors in R/R follicular and marginal zone lymphoma.
Credit available for this activity expires: 11/2/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961885?src=mkm_podcast_addon_961885






















